Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Supreme Court lifts lower-court freeze on RIFs
Cancer Policy

Supreme Court lifts lower-court freeze on RIFs

July 11, 2025
Vol.51 No.27
By Jacquelyn Cobb
Funding Opportunities

NCI, SITC immunotherapy fellowship calls for applications

July 11, 2025
Vol.51 No.27
As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
FreeGuest Editorial

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

July 03, 2025
Vol.51 No.26
By George J. Weiner and Elizabeth M. Jaffee
In Brief

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

June 27, 2025
Vol.51 No.25
The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
PodcastThe Directors

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

June 13, 2025
Vol.51 No.23
By Paul Goldberg
In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
Regulatory News

In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”

June 13, 2025
Vol.51 No.23
By Jacquelyn Cobb
George Sigounas named the first-ever chief science advisor at NCI
Cancer Policy

George Sigounas named the first-ever chief science advisor at NCI

June 06, 2025
Vol.51 No.22
By Paul Goldberg
Cancer Policy

Success rates for RPGs at NCI would plummet from 13.4% to 8.3% if Trump’s FY2026 budget is enacted

June 06, 2025
Vol.51 No.22
By Paul Goldberg
FDA booth stood empty at 2025 ASCO annual meeting
Cancer Policy

FDA booth stood empty at 2025 ASCO annual meeting

June 06, 2025
Vol.51 No.22
By Jacquelyn Cobb
Cancer Policy

ALT GOV: The HHS “resistance” on social media

June 06, 2025
Vol.51 No.22
By Claire Marie Porter

Posts navigation

Previous1…678…39Next

Trending Stories

  • OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
  • What NHS-Galleri taught us—and what it didn’t
  • The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
  • FDA clears a way for dramatic reduction in animal toxicology studies in cancer
  • Is psilocybin heading to a cancer clinic near you?
    Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research
  • As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
    The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account